Skip to main content
Erschienen in: Metabolic Brain Disease 2/2017

15.12.2016 | Original Article

The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis

verfasst von: Cristina R. Bosoi, Mariana M. Oliveira, Rafael Ochoa-Sanchez, Mélanie Tremblay, Gabriella A. Ten Have, Nicolaas E. Deutz, Christopher F. Rose, Chantal Bemeur

Erschienen in: Metabolic Brain Disease | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Muscle mass loss and hepatic encephalopathy (complex neuropsychiatric disorder) are serious complications of chronic liver disease (cirrhosis) which impact negatively on clinical outcome and quality of life and increase mortality. Liver disease leads to hyperammonemia and ammonia toxicity is believed to play a major role in the pathogenesis of hepatic encephalopathy. However, the effects of ammonia are not brain-specific and therefore may also affect other organs and tissues including muscle. The precise pathophysiological mechanisms underlying muscle wasting in chronic liver disease remains to be elucidated. In the present study, we characterized body composition as well as muscle protein synthesis in cirrhotic rats with hepatic encephalopathy using the 6-week bile duct ligation (BDL) model which recapitulates the main features of cirrhosis. Compared to sham-operated control animals, BDL rats display significant decreased gain in body weight, altered body composition, decreased gastrocnemius muscle mass and circumference as well as altered muscle morphology. Muscle protein synthesis was also significantly reduced in BDL rats compared to control animals. These findings demonstrate that the 6-week BDL experimental rat is a relevant model to study liver disease-induced muscle mass loss.
Literatur
Zurück zum Zitat Bosoi CR, Parent-Robitaille C, Anderson K et al (2011) AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile-duct ligated rats. Hepatology 53:1995–2002. doi:10.1002/hep.24273 CrossRefPubMed Bosoi CR, Parent-Robitaille C, Anderson K et al (2011) AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile-duct ligated rats. Hepatology 53:1995–2002. doi:10.​1002/​hep.​24273 CrossRefPubMed
Zurück zum Zitat Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 17:221–227CrossRefPubMed Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 17:221–227CrossRefPubMed
Zurück zum Zitat Cooper AJ, Plum F (1987) Biochemistry and physiology of brain ammonia. Physiol Rev 67:440–519PubMed Cooper AJ, Plum F (1987) Biochemistry and physiology of brain ammonia. Physiol Rev 67:440–519PubMed
Zurück zum Zitat Cosquéric G, Sebag A, Ducolombier C et al (2006) Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 96:895–901CrossRefPubMed Cosquéric G, Sebag A, Ducolombier C et al (2006) Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 96:895–901CrossRefPubMed
Zurück zum Zitat Dasarathy S, Mullen KD, Conjeevaram HS et al (2002) Preservation of portal pressure improves growth and metabolic profile in the male portacaval-shunted rat. Dig Dis Sci 47:1936–1942CrossRefPubMed Dasarathy S, Mullen KD, Conjeevaram HS et al (2002) Preservation of portal pressure improves growth and metabolic profile in the male portacaval-shunted rat. Dig Dis Sci 47:1936–1942CrossRefPubMed
Zurück zum Zitat Lai JC, Cooper AJ (1991) Neurotoxicity of ammonia and fatty acids: differential inhibition of mitochondrial dehydrogenases by ammonia and fatty acyl coenzyme a derivatives. Neurochem Res 16:795–803CrossRefPubMed Lai JC, Cooper AJ (1991) Neurotoxicity of ammonia and fatty acids: differential inhibition of mitochondrial dehydrogenases by ammonia and fatty acyl coenzyme a derivatives. Neurochem Res 16:795–803CrossRefPubMed
Zurück zum Zitat Luiking YC, Poeze M, Deutz NE (2015) Arginine infusion in patients with septic shock increases nitric oxide production without haemodynamic instability. Clin Sci 128:57–67. doi:10.1042/CS20140343 CrossRefPubMed Luiking YC, Poeze M, Deutz NE (2015) Arginine infusion in patients with septic shock increases nitric oxide production without haemodynamic instability. Clin Sci 128:57–67. doi:10.​1042/​CS20140343 CrossRefPubMed
Zurück zum Zitat Merli M, Nicolini G, Angeloni S, Riggio O (2002) Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition 18:978–986CrossRefPubMed Merli M, Nicolini G, Angeloni S, Riggio O (2002) Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition 18:978–986CrossRefPubMed
Zurück zum Zitat Metter EJ, Talbot LA, Schrager M, Conwit R (2002) Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 57:B359–B365CrossRefPubMed Metter EJ, Talbot LA, Schrager M, Conwit R (2002) Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 57:B359–B365CrossRefPubMed
Zurück zum Zitat Millwala F, Nguyen GC, Thuluvath PJ (2007) Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management. World J Gastroenterol 13:4056–4063CrossRefPubMedPubMedCentral Millwala F, Nguyen GC, Thuluvath PJ (2007) Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management. World J Gastroenterol 13:4056–4063CrossRefPubMedPubMedCentral
Zurück zum Zitat Montano-Loza AJ, Duarte-Rojo A, Bhanji RA, Rose CF (2015) Sarcopenia and Sarcopenic-Obesity are Associated with Hyperammonemia and Increased Risk of Hepatic Encephalopathy in Cirrhotics. In: Hepatology. WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, 62:933A–933A Montano-Loza AJ, Duarte-Rojo A, Bhanji RA, Rose CF (2015) Sarcopenia and Sarcopenic-Obesity are Associated with Hyperammonemia and Increased Risk of Hepatic Encephalopathy in Cirrhotics. In: Hepatology. WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, 62:933A–933A
Zurück zum Zitat Pichard C, Kyle UG, Morabia A et al (2004) Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr 79:613–618PubMed Pichard C, Kyle UG, Morabia A et al (2004) Nutritional assessment: lean body mass depletion at hospital admission is associated with an increased length of stay. Am J Clin Nutr 79:613–618PubMed
Zurück zum Zitat Shawcross DL, Sharifi Y, Canavan JB et al (2011) Infection and systemic inflammation, not ammonia, are associated with grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol 54:640–649CrossRefPubMed Shawcross DL, Sharifi Y, Canavan JB et al (2011) Infection and systemic inflammation, not ammonia, are associated with grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol 54:640–649CrossRefPubMed
Zurück zum Zitat Tandon P, Ney M, Irwin I et al (2012) Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl 18:1209–1216. doi:10.1002/lt.23495 CrossRefPubMed Tandon P, Ney M, Irwin I et al (2012) Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl 18:1209–1216. doi:10.​1002/​lt.​23495 CrossRefPubMed
Zurück zum Zitat Tilg H, Wilmer A, Vogel W et al (1992) Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264–274CrossRefPubMed Tilg H, Wilmer A, Vogel W et al (1992) Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264–274CrossRefPubMed
Zurück zum Zitat von Baehr V, Döcke WD, Plauth M et al (2000) Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 47:281–287CrossRef von Baehr V, Döcke WD, Plauth M et al (2000) Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 47:281–287CrossRef
Metadaten
Titel
The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis
verfasst von
Cristina R. Bosoi
Mariana M. Oliveira
Rafael Ochoa-Sanchez
Mélanie Tremblay
Gabriella A. Ten Have
Nicolaas E. Deutz
Christopher F. Rose
Chantal Bemeur
Publikationsdatum
15.12.2016
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 2/2017
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-016-9937-4

Weitere Artikel der Ausgabe 2/2017

Metabolic Brain Disease 2/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.